Bacteroides fragilis Enterotoxin Upregulates Matrix Metalloproteinase-7 Expression through MAPK and AP-1 Activation in Intestinal Epithelial Cells, Leading to Syndecan-2 Release

1. Introduction

Enterotoxin-producing Bacteroides fragilis (ETBF) causes several colonic diseases, including inflammation and cancer [1,2]. B. fragilis enterotoxin (BFT), a virulence factor of ETBF, is responsible for that pathogenesis [1,3]. BFT secreted by ETBF contacts intestinal epithelial cells (IECs), and the subsequent effects can induce colonic inflammation and breaks in the gut barrier. Maintaining a steady status of epithelial cell-to-cell junctions requires E-cadherin and β-catenin structures in the intestinal barrier [4]. In our previous studies of ETBF infection, we demonstrated that artificially injecting BFT into the murine ileum eventually destroyed gut integrity through villous destruction, neutrophil infiltration, and mucosal congestion [5]. In addition, BFT produced by ETBF cleaves the extracellular domain of E-cadherin that is involved in preserving the integrity of IEC barriers [6]. Matrix metalloproteinase (MMP)-7 is reported to mediate the degradation of E-cadherin in proximal tubular cells, which leads to the nuclear translocation of β-catenin [7]. The nuclear translocation of β-catenin can also control MMP-7 expression in colorectal cancer tissues [8]. We recently reported that BFT induces the translocation of β-catenin into the nuclei of IECs [9]. Based on those observations, we hypothesized that BFT might influence MMP-7 expression. However, little is known about MMP-7 expression in IECs treated with BFT.

MMPs are zinc-dependent proteinases that perform essential functions in controlling the synthesis and degradation of the basement membrane and the extracellular matrix in intestinal barriers [10]. They fulfill their functions by processing non-matrix bioactive substrates associated with membrane shedding, modifying chemokines or growth factors, and modulating the activity of other proteases [10,11]. Therefore, they regulate physiologic functions, including cell proliferation and differentiation, tissue homeostasis, and immunologic responses [10]. MMPs are structurally related but genetically distinct molecules that are classified into five subgroups depending on the structure and specificity of the substrate: (a) collagenases (MMP-1, MMP-8, and MMP-13), (b) gelatinases (MMP-2 and MMP-9), (c) stromelysins (MMP-3, MMP-10, and MMP-11), (d) matrilysins (MMP-7 and MMP-26), and (e) membrane-type (MMP-14, MMP-15, and MMP-16) [8,12]. Our study target, MMP-7, is found constitutively in the IECs and associated with tissue remodeling and the IEC response to infection [13]. In addition, secreted forms of MMP-7 can modify several pathophysiological functions such as tumor metastasis and inflammation [14].

Signals from transcription factors, including nuclear factor-kappaB (NF-κB) and activator protein-1 (AP-1), can control MMP-7 expression [15,16,17,18]. We already demonstrated that stimulating IECs with BFT can activate the signaling of those transcription factors [5,19,20,21,22]. However, there is no evidence that the BFT-induced signaling is associated with MMP-7 induction in IECs. In this study, we explored the regulation of MMP-7 expression in IECs exposed to BFT. We found that signaling pathways comprising ERK mitogen-activated protein kinases (MAPKs) and AP-1 were essential for MMP-7 induction following exposure to BFT. Those results were associated with the shedding of syndecan-2 in BFT-exposed IECs.

VSports最新版本 - 2. Results

2.1. BFT Upregulates MMP-7 Expression in IECs

Treating HCT-116 cells with BFT upregulated the expression of MMP-7 proteins (Figure 1A). In addition, CCD 841 CoN cells (a normal colonic epithelial cell line) treated with BFT also increased their MMP-7 expression, as assessed by immunoblotting (Figure 1B). In another experiment, the levels of soluble MMP-7 were measured with an ELISA kit using conditioned medium from HCT-116 cells treated with BFT. As shown in Figure 1C, a significant increase in soluble MMP-7 was first noted 6 h after treatment with BFT and continued to 24 h post-stimulation.

2.2. Activation of NF-κB Is Not Associated with MMP-7 Induction in IECs following BFT Stimulation

The NF-κB transcription factor was activated in BFT-exposed HCT-116 cells (Figure 2A). We next used transfection models to examine whether NF-κB activation was linked to MMP-7 upregulation in IECs. Transfection with lentivirus-IκBα-AA decreased the nuclear phospho-p65 signal to the control level after BFT treatment (Figure 2B, top panels). In this experiment, transfection with lentivirus-IκBα-AA did not significantly change the expression of MMP-7 in HCT-116 cells (Figure 2B, bottom panels). In another experiment, we used p65 siRNA to inhibit NF-κB activity. p65 siRNA suppressed the nuclear protein expression of phospho-p65 in BFT-treated cells (Figure 2C, top panels). However, no change in MMP-7 expression was observed between the cells transfected with p65 siRNA and untransfected cells (Figure 2C, bottom panels).

2.3. AP-1 Is Involved in the Upregulation of MMP-7 in BFT-Stimulated IECs

The transcription factor AP-1 was also activated in BFT-exposed HCT-116 cells (Figure 3A). Transfection with lentivirus-dn-c-jun suppressed the phospho-c-jun signal to control levels in BFT-stimulated HCT-116 cells, whereas the control GFP did not diminish (Figure 3B, top panels). In this experiment, transfection with lentivirus-dn-c-jun significantly reduced the levels of MMP-7 expression in HCT-116 cells (Figure 3B, bottom panels). We next used siRNA against c-jun to suppress AP-1 activity. As shown in the top panels of Figure 3C, transfection with siRNA against c-jun inhibited the signals of nuclear phospho-c-jun. In this experiment, c-jun siRNA significantly attenuated MMP-7 expression under BFT-stimulation conditions (Figure 3C, bottom panels).

V体育ios版 - 2.4. ERK Is Involved in the Upregulation of MMP-7 in BFT-Stimulated IECs

BFT stimulation activated the phosphorylated forms of MAPK proteins such as ERK1/2, p38, and JNK in HCT-116 cells (Figure 4A). CCD 841 CoN cells treated with BFT also increased their production of the phosphorylated form of each MAPK (Figure 4B). To evaluate the effects of MAPK inhibition on the MMP-7 induction in BFT-treated cells, we used chemical kinase inhibitors as previously described [23,24]. Under BFT-stimulated conditions, MMP-7 expression was first inhibited significantly at 10 μM concentration of PD98059 (ERK inhibitor). In contrast, SB203580 (p38 inhibitor) and SP600125 (JNK inhibitor) first significantly inhibited MMP-7 expression at a concentration of 50 μM (Figure 4C).

We next performed experiments using lentiviral systems containing dominant-negative plasmids to confirm those findings. Transfection with lentiviruses containing a dominant-negative Erk2 plasmid (lentivirus-dn-Erk) suppressed the phosphorylation of Elk1 proteins in HCT-116 cells (Figure 5A, top panels). In this experiment, the lentivirus-dn-Erk significantly decreased MMP-7 expression following BFT stimulation (Figure 5A, bottom panels). In contrast, transfection with lentiviruses containing a dominant-negative p38 plasmid (lentivirus-dn-p38) did not significantly change the expression of MMP-7 in BFT-stimulated HCT-116 cells (Figure 5B). Lentiviral infection with a dominant-negative JNK1 plasmid (lentivirus-dn-JNK) did not affect MMP-7 expression, either (Figure 5C). To further investigate ERK-induced AP-1 activation, we used ELISA kits to measure AP-activity. Infection with lentivirus-dn-Erk reduced AP-1 activity in cells treated with BFT (Figure 5D). Thus, exposing IECs to BFT might trigger a signaling pathway comprising ERK, AP-1, and MMP-7 induction.

2.5. BFT-Induced MMP-7 Upregulation Is Associated with Syndecan-2 Release in IECs

Because the extracellular domain of syndecan-2 is cleaved by MMP-7 in colon cancer cells [16,25], it is likely that MMP-7 is involved in syndecan-2 shedding when BFT contacts IECs. To investigate that hypothesis, we first examined whether BFT could induce syndecan-2 release in IECs. As shown in the top panels of Figure 6A, treating HCT-116 cells with BFT enhanced the levels of soluble syndecan-2. CCD 841 CoN cells exposed to BFT also increased soluble syndecan-2 levels in slot blot and conditioned culture supernatant assessments (Figure 6A, bottom panel). In the following experiment, the concentration of soluble syndecan-2 was measured using an ELISA kit with conditioned culture supernatants from HCT-116 cells treated with BFT. As shown in Figure 6B, a significant increase in soluble syndecan-2 was first noted 12 h following BFT exposure and continued to 24 h post-stimulation. The increase in soluble syndecan-2 depended on the concentration of BFT used for stimulation (Figure 6C).

We next examined whether BFT-induced MMP-7 upregulation is related to syndecan-2 release in IECs. A transfection model with siRNA was used to suppress MMP-7 signals in BFT-exposed cells. The experiment using whole-cell lysate obtained from MMP-7 siRNA-transfected cells showed the apparent suppression of MMP-7 signals under BFT-stimulated conditions (Figure 7A, top panels). As assessed by slot blotting and the conditioned culture supernatant, MMP-7 siRNA transfection led to a significant reduction in soluble syndecan-2 compared with untransfected cells stimulated with BFT, and transfection with NS-RNA as a control had no significant effect (Figure 7A, bottom panels). In another experiment, BFT significantly increased both soluble MMP-7 and soluble syndecan-2 in the conditioned media. In that experiment, transfection with MMP-7 siRNA significantly decreased the levels of soluble MMP-7 and soluble syndecan-2 (Figure 7B). In the next experiment, CCD 841 CoN cells were preincubated with GM6001 (10 μM), a broad-spectrum MMP inhibitor, and then treated with BFT. As shown in Figure 7C, GM6001 significantly suppressed syndecan-2 release compared with untreated cells. Those results might allow the establishment of a theory of MMP-7-dependent induction of syndecan-2 release in IECs exposed to BFT.

2.6. AP-1 Signaling Is Involved in Syndecan-2 Release in IECs Stimulated with BFT

We used a lentivirus-transfection system to examine the involvement of transcriptional factors in syndecan-2 shedding. In the experiment that used lentivirus-IκBα-AA transfection (Figure 2B), suppressing NF-κB activity did not affect soluble MMP-7 or syndecan-2 upon BFT exposure (Figure 8A). In contrast, transfection with lentivirus-dn-c-jun significantly reduced the levels of soluble MMP-7 and syndecan-2 in HCT-116 cells (Figure 8B). Primary intestinal epithelial CCD 841 CoN cells were pre-incubated with Bay 11-7082 (NF-κB inhibitor) or SR11302 (AP-1 inhibitor) for 30 min, and then stimulated with BFT to confirm those results. As shown in Figure 8C, pretreating CCD 841 CoN cells with SR11302 resulted in a significant decrease in soluble MMP-7 and soluble syndecan-2 compared with treatment with BFT alone. However, pretreatment with Bay 11-7082 did not significantly change the BFT-induced levels of soluble MMP-7 and syndecan-2.

2.7. MMP-7-Associated ERK Activation Is Essential for Syndecan-2 Release in BFT-Stimulated IECs

In the previous experiments, BFT induced the phosphorylated forms of MAPK proteins such as p38, ERK, and JNK in HCT-116 cells (Figure 4A,B). We used lentiviral systems containing dominant-negative plasmids (Figure 5A–C) to assess the effects of MAPK signals on syndecan-2 release. Lentiviral infection with dn-Erk significantly decreased MMP-7 expression compared with the untransfected control (Figure 9A). But lentiviral infection with dn-p38 or dn-JNK produced no changes in MMP-7 expression under BFT-stimulated conditions. Similar results were obtained for soluble syndecan-2 levels in cells transfected with dn-Erk under BFT-stimulated conditions (Figure 9B).

3. Discussion

IECs exposed to BFT can express mediators, such as IL-8 and β-catenin, and transcription factors, such as AP-1 and NF-κB, to regulate the expression of those effector molecules [5,9,19,20,21,22]. Concurrently, BFT can affect several components needed to maintain the IE barrier. In this study, we showed that BFT upregulates the expression of MMP-7 and that the enhanced MMP-7 expression is associated with syndecan-2 release in IECs stimulated with BFT.

Many MMPs are synthesized and then secreted as proenzymes; MMP-7 is a soluble-type MMP [26,27] that can be upregulated in IECs [28]. MMP-7 degrades a variety of matrix substrates such as elastin, gelatin, and proteoglycans. Because secreted MMP-7 might play a role in the pathogenesis of early-stage colon tumors [28], we measured its form using an ELISA kit and conditioned medium from BFT-treated cells. The cellular forms of MMP-7 were also measured using Western blotting and cell lysates in this study. Our results show that BFT can increase both the cellular and secreted forms of MMP-7 in IECs.

Which transcription factor is responsible for MMP-7 induction is controversial. For example, isoproterenol might induce AP-1-mediated MMP-7 expression in gastric cancer cells [18], and hydrogen peroxide caused the expression of MMP-7 molecules in SW-620 human colon cancer cells via an AP-1 signaling pathway [15]. In contrast, IL-1α- or TNF-α-treated IECs increased their expression of MMP-7 proteins via an NF-κB activation pathway [16,17]. In this study, exposing HCT-116 cells to BFT increased MMP-7 protein expression, and BFT-activated AP-1 signaling was involved in MMP-7 upregulation. Based on those findings, we investigated the upstream signaling associated with BFT-induced MMP-7 upregulation.

MAPK signaling is known to be an essential piece underlying the expression of several target proteins, including MMP-7 and syndecan-2. Several reports have demonstrated MAPK signaling-associated MMP-7 expression. For example, animal experiments showed that treating mice with JNK- or ERK-specific inhibitors decreased MMP-7 expression in tumor tissue, suggesting that MMP-7 induction occurs via the activation of JNK and ERK [29]. In addition, human peritoneal mesothelial cells express MMP-7 molecules via ERK activation [30]. Stimulating HT-29 cells with IL-1α enhanced their MMP-7 protein secretion via activation of phospho-ERK and phospho-p38 MAPK molecules [16]. In this study, the suppression of ERK molecules suppressed both the AP-1 signal and MMP-7 expression in primary intestinal epithelial CCD 841 CoN and HCT-116 cells treated with BFT. In contrast, inhibiting p38 or JNK activity did not influence the MMP-7 expression in IECs stimulated with BFT. Therefore, the mechanisms of ERK-associated MMP-7 induction and AP-1 activation in IECs might be stimulator-specific and seem to depend on the type of IECs.

A previous study reported that BFT could not activate the MMP-7 signaling pathway because no active form of the MMP-7 molecules was observed in Western blot assays of control or BFT-stimulated HT29/C1 cells [31]. Nevertheless, we found that MMP-7 molecules, one of the constitutive components of IECs, were upregulated in IECs exposed to BFT and that enhanced MMP-7 expression was related to syndecan-2 release. HT-29 cell lines constitutively express high levels of MMP-7 proteins in the steady state. In contrast, HCT-116 cell lines express a relatively low level of MMP-7 molecules in their stable condition [4]. Based on that finding, we used HCT-116 cell lines in this study. Nevertheless, we did not experiment with immunofluorescence experiment to confirm the status of MMP-7. It seems necessary to experiment on this issue.

Syndecans are the dominant forms of surface heparan sulfate proteoglycans in eukaryotic cells. Among microbial infections, Brucella melitensis, Pseudomonas aeruginosa, Neisseria gonorrhoeae, and other bacteria such as Staphylococcus and Streptococcus species attach and invade hosts by acting together with syndecan molecules [32,33,34,35]. Syndecan-2 is known to be involved in a variety of functions such as cell proliferation, migration, and interaction between cells and intercellular substances as well as microbial interaction. For example, syndecan-2 expressed on the surface of dendritic cells binds to HIV, after which syndecan-2 facilitates viral transmission to CD4-positive T cells [36]. The syndecan-2 knock-out state diminished both phagocytic activity against apoptotic neutrophils and the ability to convert macrophages from a proinflammatory phenotype to a pro-resolution one in mesenchymal stromal cells [37]. Helicobacter pylori infection also increased the soluble level of syndecan-2 released from epithelial cells [28]. However, nothing has been reported about the role of syndecan-2 in ETBF infection until the results of this study, which is the first report to elucidate the role of syndecan-2 in ETBF infection.

We found that PD98059 (ERK inhibitor) was superior to both SB203580 and SP600125 in diminishing MMP-7 upregulation and syndecan-2 release. We confirmed those findings by using a lentivirus-based knockdown strategy. Considering that the extracellular domain of shed syndecan-2 plays an essential role in the pro-MMP-7 activation process in IECs [38], the syndecan-2 release induced by BFT could be involved in the pro-MMP-7 activation process in IECs. Further exploration is needed to clarify the roles played by the syndecan-2 released in ETBF infection.

Based on the present findings, we hypothesize that BFT activates a signaling cascade comprising ERK and AP-1 activation that is related to MMP-7 upregulation and syndecan-2 release in IECs. Our proposal could be a fruitful avenue for future investigation of ETBF infection. Nevertheless, this study has several limitations. We applied a pharmacological dose of BFT to promote MMP-7 upregulation and the syndecan-2 release. In addition, we did not examine whether the released syndecan-2 controlled MMP-7 upregulation or the pro-MMP-7 activation process in IECs stimulated with BFT. Future exploration is needed to clarify whether ETBF infection affects MMP-7 expression and syndecan-2 release in vivo and whether the released syndecan-2 regulates the pro-MMP-7 activation process in BFT-exposed IECs. We did not perform cell migration analysis to evaluate the effect of MMP-7 production. Therefore, it is necessary for experiments to study whether MMP7 can promote cell migration using wound-healing assays and Transwell migration and invasion assays. In conclusion, MMP-7 upregulation in BFT-exposed IECs was closely related to syndecan-2 release via the BFT-induced activation of AP-1 and ERK signals.

"VSports最新版本" 4. Materials and Methods

4.1. Reagents

We used the following reagents in this study: antibiotics (mixture of 100 μg/mL of streptomycin and 100 units/mL of penicillin), Trizol, Ca²⁺- and Mg²⁺-free Hank’s balanced salt solution (GIBCO BRL, Gaithersburg, MD, USA); Eagle’s minimum essential medium (EMEM), McCoy’s 5a medium, and fetal bovine serum (FBS) (American Type Culture Collection (ATCC), Manassas, VA, USA); Bay 11-7085, SB203580, PD98059, and SP600125 (Calbiochem, La Jolla, CA, USA); GM6001 and Ponceau S (Sigma-Aldrich, St. Louis, MO, USA); and SR11302 (MedChemExpress, Monmouth Junction, NJ, USA).

The following antibodies were used in this study: rabbit monoclonal antibodies (mAbs) against phospho-IκBα and rabbit polyclonal Abs against phospho-p65, phospho-c-jun, pan-extracellular signal-regulated kinase 1/2 (ERK1/2, p44/p42), phospho-ERK1/2, pan-p38, phospho-p38, pan-JNK (p54/p46), and phospho-JNK (Cell Signaling Technology, Inc., Beverly, MA, USA); mouse mAb against human MMP-7 (R&D Systems, Minneapolis, MN, USA); rabbit polyclonal Ab against human syndecan-2 (Thermo Fisher Scientific, Waltham, MA, USA); and mouse mAbs against actin and lamin B, goat anti-mouse, and anti-rabbit secondary Abs conjugated to horseradish peroxidase (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA).

4.2. Cell Culture Conditions and Purification of BFT

Cell culture conditions were identical to those reported in our previous studies [9,22,39]. The human colonic epithelial HCT-116 cell line (ATCC CCL 247) was cultured in McCoy’s 5a medium complemented with 10% FBS and antibiotics. Normal colonic epithelial CCD 841 CoN cells (ATCC CRL-1790) were cultured with EMEM with 10% FBS and 1 mM sodium pyruvate [9,22]. BFT was purified from culture supernatants of a toxigenic B. fragilis strain (ATCC 43858) using protocols detailed in our previous reports [9,19,20,21,22,39].

4.3. Transfection Assay

Lentiviral systems containing mammalian expression vectors were used to block NF-κB, AP-1, or MAPK activation, as described previously [9,21,22]. Lentiviral vectors and effective viruses were supported by BioCore at the Institute of Biomedical Science (Seoul, Korea). Experiments related to transfection were performed according to the relevant manufacturer instructions [9,21,22].

In this study, we used small interfering RNA (siRNA) against MMP-7, NF-κB p65, c-jun and a non-silencing siRNA (NS-RNA) as the negative control (Santa Cruz Biotechnology, Inc.). Transfected cells were incubated for 48 h before BFT treatment. Transfection experiments were performed according to a protocol described previously [9,21,22].

4.4. Immunoblots and ELISA

Expressed proteins were detected using immunoblot analyses as described previously [9,21,22]. An amount of 15 to 50 µg of protein per lane were size-fractionated on a polyacrylamide minigel (Mini-PROTEIN II, Bio-Rad) and transferred to a nitrocellulose membrane (0.1-μm pore size; MilliporeSigma, Burlington, MA, USA) via electrophoretic transfer. Secondary Abs conjugated to horseradish peroxidase were reacted with the target proteins bound with the primary Ab. The reaction signals were detected using a West-Q Chemiluminescent Substrate Kit Plus (GenDEPOT, Katy, TX, USA) and X-ray film exposure.

For slot blotting, the culture supernatants were slot-blotted to a PVDF membrane (MilliporeSigma) using a Bio-Dot SF microfiltration apparatus (Bio-Rad, Hercules, CA, USA). Equal amounts of protein were loaded onto the slot blots. Before blotting, the membrane was stained with Ponceau S. The slot blotting and immunoreaction with the anti-syndecan-2 Ab were performed according to a previously described method [16]. The reaction signals were detected using a West-Q Chemiluminescent Substrate Kit Plus (GenDEPOT) and X-ray film exposure.

A p44/42 MAP kinase assay kit (Cell Signaling Technology) was used to measure phospho-Elk1 molecules as described previously [9,21,22]. An ELISA kit for Trans^AM® AP-1 was obtained from Active Motif (Carlsbad, CA, USA). Equal volumes of conditioned media were obtained from cells and the protein levels in the culture supernatants following BFT stimulation were measured using commercially available ELISA kits for soluble MMP-7 (Invitrogen, Carlsbad, CA, USA) and soluble syndecan-2 (LifeSpan Biosciences Inc., Seattle, WA, USA). Each assay was performed according to the relevant manufacturer instructions.

4.5. Statistical Analyses

Data are indicated as the mean ± SEM and the Mann–Whitney t-test was used for the statistical analyses. A p value less than 0.05 was considered statistically significant.